Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Brinton LA, et al. Among authors: althuis md. Obstet Gynecol. 2004 Jun;103(6):1194-203. doi: 10.1097/01.AOG.0000128139.92313.74. Obstet Gynecol. 2004. PMID: 15172852
Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ. Brinton LA, et al. Among authors: althuis md. Hum Reprod. 2004 Sep;19(9):2005-13. doi: 10.1093/humrep/deh371. Epub 2004 Jun 24. Hum Reprod. 2004. PMID: 15217997
Causes of infertility as predictors of subsequent cancer risk.
Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, Moghissi KS. Brinton LA, et al. Among authors: althuis md. Epidemiology. 2005 Jul;16(4):500-7. doi: 10.1097/01.ede.0000164812.02181.d5. Epidemiology. 2005. PMID: 15951668
Ovarian cancer risk associated with varying causes of infertility.
Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Brinton LA, et al. Among authors: althuis md. Fertil Steril. 2004 Aug;82(2):405-14. doi: 10.1016/j.fertnstert.2004.02.109. Fertil Steril. 2004. PMID: 15302291
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page